RIGEL PHARMACEUTICALS, INC. Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value
RIGEL PHARMACEUTICALS, INC. (RIGL) had Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value of $69.36 million as of 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue · last filed 2019-05-07
- 2019-03-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $69.36M.
- 2018-12-31: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $50.45M.
- 2018-09-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $53.41M.
- 2018-06-30: Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value $43.08M.
| Period end | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value |
|---|---|
| 2019-03-31 | $69.36M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $50.45M 10-K · filed 2019-02-28 |
| 2018-09-30 | $53.41M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $43.08M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $48.42M 10-Q · filed 2018-05-01 |
| 2017-12-31 | $60.74M 10-K · filed 2018-03-06 |
| 2017-09-30 | $25.92M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $39.38M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $48.53M 10-Q · filed 2017-05-02 |
| 2016-12-31 | $27.11M 10-K · filed 2017-03-07 |
| 2016-03-31 | $24.40M 10-Q · filed 2016-05-03 |
| 2015-12-31 | $67.39M 10-K · filed 2016-03-08 |
| 2015-09-30 | $21.91M 10-Q · filed 2015-11-03 |
| 2015-06-30 | $53.88M 10-Q · filed 2015-08-04 |
| 2015-03-31 | $51.22M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $57.56M 10-K · filed 2015-03-03 |
| 2014-09-30 | $42.09M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $36.42M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $64.46M 10-Q · filed 2014-05-07 |
| 2013-12-31 | $31.25M 10-K · filed 2014-03-04 |
| 2013-09-30 | $31.26M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $98.60M 10-Q · filed 2013-08-06 |
| 2012-12-31 | $78.51M 10-K · filed 2013-03-05 |
| 2012-06-30 | $78.17M 10-Q · filed 2012-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |